[1
]
Ovarian Cancer Cell Laboratory, Weatherall Institute of Molecular Medicine, University
of Oxford, Headington, Oxford OX3 9DS, UK; Nuffield Department of Obstetrics and Gynaecology,
University of Oxford, Women's Centre, John Radcliffe Hospital, Oxford OX3 9DU, UK.
[2
]
Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe
Boulevard, Houston, TX 77030, USA; Center for RNAi and Non-Coding RNA, The University
of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.
[3
]
Ovarian Cancer Cell Laboratory, Weatherall Institute of Molecular Medicine, University
of Oxford, Headington, Oxford OX3 9DS, UK; Nuffield Department of Obstetrics and Gynaecology,
University of Oxford, Women's Centre, John Radcliffe Hospital, Oxford OX3 9DU, UK;
Structural Genomics Consortium, Nuffield Department of Medicine, University of Oxford,
Old Road Campus Research Building, Oxford OX3 7DQ, UK.
[4
]
Ovarian Cancer Cell Laboratory, Weatherall Institute of Molecular Medicine, University
of Oxford, Headington, Oxford OX3 9DS, UK; Nuffield Department of Obstetrics and Gynaecology,
University of Oxford, Women's Centre, John Radcliffe Hospital, Oxford OX3 9DU, UK;
Biochemistry Department, Faculty of Science, King Abdulaziz University, Jeddah 21551,
Saudi Arabia.
[5
]
Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe
Boulevard, Houston, TX 77030, USA.
[6
]
Center for RNAi and Non-Coding RNA, The University of Texas MD Anderson Cancer Center,
1515 Holcombe Boulevard, Houston, TX 77030, USA; Department of Experimental Therapeutics,
University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA.
[7
]
Structural Genomics Consortium, Nuffield Department of Medicine, University of Oxford,
Old Road Campus Research Building, Oxford OX3 7DQ, UK.
[8
]
Department of Oncology, University of Oxford, Old Road Campus Research Building, Roosevelt
Drive, Oxford OX3 7DQ, UK.
[9
]
Department of Histopathology, Oxford University Hospitals, Oxford OX3 9DU, UK.
[10
]
Department of Experimental Therapeutics, University of Texas M.D. Anderson Cancer
Center, Houston, TX 77030, USA.
[11
]
Division of Gene Regulation, Institute for Advanced Medical Research, School of Medicine,
Keio University, Tokyo 160-8582, Japan.
[12
]
Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School,
Boston, MA 02115, USA; Department of Cancer Biology, Dana Farber Cancer Institute,
Boston, MA 02215, USA.
[13
]
Nuffield Department of Medicine, Target Discovery Institute, University of Oxford,
Oxford OX3 7FZ, UK.
[14
]
Wellcome Trust Centre for Human Genetics, NIHR Biomedical Research Centre, Roosevelt
Drive, Oxford OX3 7BN, UK; Department of Statistics, University of Oxford, 1 South
Parks Road, Oxford OX1 3TG, UK.
[15
]
Department of Obstetrics and Gynecology, Faculty of Life Sciences, Kumamoto University,
Kumamoto 860-8556, Japan.
[16
]
Structural Genomics Consortium, Nuffield Department of Medicine, University of Oxford,
Old Road Campus Research Building, Oxford OX3 7DQ, UK; Nuffield Department of Medicine,
Target Discovery Institute, University of Oxford, Oxford OX3 7FZ, UK; Goethe-University
Frankfurt, Institute for Pharmaceutical Chemistry and Buchmann Institute for Life
Sciences, Riedberg Campus, 60438 Frankfurt am Main, Germany.
[17
]
Ovarian Cancer Cell Laboratory, Weatherall Institute of Molecular Medicine, University
of Oxford, Headington, Oxford OX3 9DS, UK; Nuffield Department of Obstetrics and Gynaecology,
University of Oxford, Women's Centre, John Radcliffe Hospital, Oxford OX3 9DU, UK.
Electronic address: ahmed.ahmed@obs-gyn.ox.ac.uk.
